FLVC1_HUMAN - dbPTM
FLVC1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID FLVC1_HUMAN
UniProt AC Q9Y5Y0
Protein Name Feline leukemia virus subgroup C receptor-related protein 1
Gene Name FLVCR1
Organism Homo sapiens (Human).
Sequence Length 555
Subcellular Localization Isoform 1: Cell membrane
Multi-pass membrane protein.
Isoform 2: Mitochondrion membrane
Multi-pass membrane protein.
Protein Description Isoform 1: Heme transporter that exports cytoplasmic heme. It can also export coproporphyrin and protoporphyrin IX, which are both intermediate products in the heme biosynthetic pathway. Does not export bilirubin. Heme export depends on the presence of HPX and is required to maintain intracellular free heme balance, protecting cells from heme toxicity. Heme export provides protection from heme or ferrous iron toxicities in liver, brain, sensory neurons and during erythtopoiesis, a process in which heme synthesis intensifies. Causes susceptibility to FeLV-C in vitro.; Isoform 2: Heme transporter that promotes heme efflux from the mitochondrion to the cytoplasm. Essential for erythroid differentiation..
Protein Sequence MARPDDEEGAAVAPGHPLAKGYLPLPRGAPVGKESVELQNGPKAGTFPVNGAPRDSLAAASGVLGGPQTPLAPEEETQARLLPAGAGAETPGAESSPLPLTALSPRRFVVLLIFSLYSLVNAFQWIQYSIISNVFEGFYGVTLLHIDWLSMVYMLAYVPLIFPATWLLDTRGLRLTALLGSGLNCLGAWIKCGSVQQHLFWVTMLGQCLCSVAQVFILGLPSRIASVWFGPKEVSTACATAVLGNQLGTAVGFLLPPVLVPNTQNDTNLLACNISTMFYGTSAVATLLFILTAIAFKEKPRYPPSQAQAALQDSPPEEYSYKKSIRNLFKNIPFVLLLITYGIMTGAFYSVSTLLNQMILTYYEGEEVNAGRIGLTLVVAGMVGSILCGLWLDYTKTYKQTTLIVYILSFIGMVIFTFTLDLRYIIIVFVTGGVLGFFMTGYLPLGFEFAVEITYPESEGTSSGLLNASAQIFGILFTLAQGKLTSDYGPKAGNIFLCVWMFIGIILTALIKSDLRRHNINIGITNVDVKAIPADSPTDQEPKTVMLSKQSESAI
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MARPDDEEG
------CCCCCCCCC
31.54-
20UbiquitinationAPGHPLAKGYLPLPR
CCCCCCCCCCCCCCC
56.63-
22PhosphorylationGHPLAKGYLPLPRGA
CCCCCCCCCCCCCCC
12.3925884760
33UbiquitinationPRGAPVGKESVELQN
CCCCCCCCCCEECCC
47.2321906983
43UbiquitinationVELQNGPKAGTFPVN
EECCCCCCCCCCCCC
61.93-
46PhosphorylationQNGPKAGTFPVNGAP
CCCCCCCCCCCCCCC
29.6228122231
56PhosphorylationVNGAPRDSLAAASGV
CCCCCHHHHHHHHCC
22.6130243723
61PhosphorylationRDSLAAASGVLGGPQ
HHHHHHHHCCCCCCC
25.3830243723
69PhosphorylationGVLGGPQTPLAPEEE
CCCCCCCCCCCCHHH
24.3330243723
90PhosphorylationPAGAGAETPGAESSP
CCCCCCCCCCCCCCC
26.8726657352
95PhosphorylationAETPGAESSPLPLTA
CCCCCCCCCCCCCHH
36.4027732954
96PhosphorylationETPGAESSPLPLTAL
CCCCCCCCCCCCHHC
23.2027732954
101PhosphorylationESSPLPLTALSPRRF
CCCCCCCHHCCHHHH
24.5027732954
104PhosphorylationPLPLTALSPRRFVVL
CCCCHHCCHHHHHHH
17.5624719451
265N-linked_GlycosylationVLVPNTQNDTNLLAC
EECCCCCCCCCEEEE
56.91UniProtKB CARBOHYD
273N-linked_GlycosylationDTNLLACNISTMFYG
CCCEEEEEHHHHHHC
26.16UniProtKB CARBOHYD
322UbiquitinationPPEEYSYKKSIRNLF
CCHHHCHHHHHHHHH
33.8221906983
323UbiquitinationPEEYSYKKSIRNLFK
CHHHCHHHHHHHHHH
42.77-
398PhosphorylationWLDYTKTYKQTTLIV
HHCCCCCCCHHHHHH
11.5822210691
401PhosphorylationYTKTYKQTTLIVYIL
CCCCCCHHHHHHHHH
21.2922210691
417PhosphorylationFIGMVIFTFTLDLRY
HHHHHHHHHHCCCCC
12.4622210691
419PhosphorylationGMVIFTFTLDLRYII
HHHHHHHHCCCCCEE
19.1222210691
530UbiquitinationGITNVDVKAIPADSP
EEEEECEEECCCCCC
35.8121906983
536PhosphorylationVKAIPADSPTDQEPK
EEECCCCCCCCCCCC
31.6330266825
538PhosphorylationAIPADSPTDQEPKTV
ECCCCCCCCCCCCEE
55.0230266825
543UbiquitinationSPTDQEPKTVMLSKQ
CCCCCCCCEEEECCC
53.66-
544PhosphorylationPTDQEPKTVMLSKQS
CCCCCCCEEEECCCC
23.12-
548PhosphorylationEPKTVMLSKQSESAI
CCCEEEECCCCCCCC
15.56-
549UbiquitinationPKTVMLSKQSESAI-
CCEEEECCCCCCCC-
54.61-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of FLVC1_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of FLVC1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of FLVC1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Oops, there are no PPI records of FLVC1_HUMAN !!

Drug and Disease Associations
Kegg Disease
H01036 Posterior column ataxia with retinitis pigmentosa (PCARP)
OMIM Disease
609033Posterior column ataxia with retinitis pigmentosa (PCARP)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of FLVC1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-536, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-56, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-536, AND MASS SPECTROMETRY.

TOP